» Articles » PMID: 39148052

Validity of Evaluation Scales for Post-stroke Depression: a Systematic Review and Meta-analysis

Overview
Journal BMC Neurol
Publisher Biomed Central
Specialty Neurology
Date 2024 Aug 15
PMID 39148052
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Post-stroke depression (PSD) is closely associated with poor stroke prognosis. However, there are some challenges in identifying and assessing PSD. This study aimed to identify scales for PSD diagnosis, assessment, and follow-up that are straightforward, accurate, efficient, and reproducible.

Methods: A systematic literature search was conducted in 7 electronic databases from January 1985 to December 2023.

Results: Thirty-two studies were included, the Patient Health Questionnaire-9 (PHQ-9) and Hamilton Depression Scale (HDRS) had higher diagnostic accuracy for PSD. The sensitivity, specificity, and diagnostic odds ratio of PHQ-9 or diagnosing any depression were 0.82, 0.87, and 29 respectively. And for HDRS, used for diagnosing major depression, the scores were 0.92, 0.89, and 94. Furthermore, these two scales also had higher diagnostic accuracy in assessing depressive symptoms during both the acute and chronic phases of stroke. In patients with post-stroke aphasia and cognitive impairment, highly diagnostic scales have not been identified for assessing depressive symptoms yet.

Conclusions: The PHQ-9 and HDRS scales are recommended to assess PSD. HDRS, which demonstrates high diagnostic performance, can replace structured interviews based on diagnostic criteria.

References
1.
Prisnie J, Fiest K, Coutts S, Patten S, Atta C, Blaikie L . Validating screening tools for depression in stroke and transient ischemic attack patients. Int J Psychiatry Med. 2016; 51(3):262-77. DOI: 10.1177/0091217416652616. View

2.
Sagen U, Vik T, Moum T, Morland T, Finset A, Dammen T . Screening for anxiety and depression after stroke: comparison of the hospital anxiety and depression scale and the Montgomery and Asberg depression rating scale. J Psychosom Res. 2009; 67(4):325-32. DOI: 10.1016/j.jpsychores.2009.03.007. View

3.
Battle D . Diagnostic and Statistical Manual of Mental Disorders (DSM). Codas. 2014; 25(2):191-2. DOI: 10.1590/s2317-17822013000200017. View

4.
. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a.... Lancet. 2024; 403(10440):2133-2161. PMC: 11122111. DOI: 10.1016/S0140-6736(24)00757-8. View

5.
Kowalska K, Pasinska P, Klimiec-Moskal E, Pera J, Slowik A, Klimkowicz-Mrowiec A . C-reactive protein and post-stroke depressive symptoms. Sci Rep. 2020; 10(1):1431. PMC: 6989519. DOI: 10.1038/s41598-020-58478-6. View